Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07175311

Vascular Changes Associated With Endophthalmitis.

Status
Recruiting
Phase
Study type
Observational
Enrollment
71 (estimated)
Sponsor
Asociación para Evitar la Ceguera en México · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to describe and investigate vascular changes associated with exogenous endophthalmitis, as well as to create a photo library where they are evidenced

Detailed description

The implementation of multimodal imaging studies during the diagnosis and follow-up of patients with endophthalmitis may help identify, characterize, and differentiate between changes associated with host immune response, drug toxicity, or ischemia, thereby opening the possibility of implementing early treatments that lead to a better final prognosis. It is designed as a Prospective, Longitudinal, Observational, and Descriptive study. The population will be patients of the retina and vitreous service of Asociación para Evitar la Ceguera en México, who have a complete clinical record (age, sex, pathological personal history, non-pathological personal history, heredofamilial history, ophthalmologic history, allergies, medications, ophthalmologic examination with visual acuity, intraocular pressure at each visit), signed informed consent and with a history of exogenous or endogenous endophthalmitis with clear resolution criteria and clear means one week and one month after meeting the resolution criteria to be able to perform fluorescein angiography at both visits.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMultimodal imaging findingsFundus photography, Optical Coherence Tomography, and Fluorescein Angiography will be performed 7 days after meeting the criteria for inactivation of endophthalmitis, as outlined in the MEX-ESG guidelines. These imaging tests will be repeated one month after meeting the inactivation criteria.

Timeline

Start date
2024-11-01
Primary completion
2026-02-01
Completion
2026-03-01
First posted
2025-09-16
Last updated
2025-09-16

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT07175311. Inclusion in this directory is not an endorsement.